Transaction #507 · Form 4 · 0001193125-25-240662
ENDRA Life Sciences Inc. · Stock award · Warrants
ENDRA Life Sciences Inc. · Transacted October 10, 2025 · Filed October 15, 2025
What does this filing report?
An SEC Form 4 filing for ENDRA Life Sciences Inc. records a stock award involving Warrants on October 10, 2025. The reported quantity was 141,644. The filing date is October 15, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ENDRA Life Sciences Inc.
- Company CIK
- 0001681682
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 141,644
- Reported price
- 7.06 · See footnotes
- Reference value
- 1,000,006.64
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 141,644
- Ownership description
- Not reported
- SEC acceptance time
- Oct 15, 2025, 9:54 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- DIGIANDOMENICO ANTHONY ↗
Director
CIK 0001083544
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 141,644
- Conversion / exercise price
- 6.81
- Exercise date
- October 15, 2025
- Expiration date
- October 15, 2030
Filing footnotes & remarks
- F1
- The shares of Common Stock and Warrants were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended.
- F2
- Each share of Common Stock was purchased together with Warrants exercisable for two shares of Common Stock.
- F3
- Includes unvested restricted stock units.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.